
Journal of Inorganic Biochemistry, Journal Year: 2024, Volume and Issue: 264, P. 112788 - 112788
Published: Nov. 29, 2024
Journal of Inorganic Biochemistry, Journal Year: 2024, Volume and Issue: 264, P. 112788 - 112788
Published: Nov. 29, 2024
Discover Oncology, Journal Year: 2024, Volume and Issue: 15(1)
Published: Jan. 5, 2024
Abstract In the field of experimental therapeutics for oncology purposes researchers are continuously evaluating toxicity novel treatment approaches against cancer cells. Within this topic research, it is highly critical to define parameters that denote when cells perturbed in their functionality by a new investigational drug. As goal these achieve cellular demise, then what use and do they mean terms assessing such cell death importance. comment article we highlight definition vitality differentiate from viability, further clonogenic survival chronic fashion. Additionally, recommend term cytotoxicity as general descriptor indicating towards cell, but within encourage sub-classify either cytostasis (i.e., does not allow grow kill either), or lethality (when dies response treatment). A more precise should help advance better defining mechanisms action drugs.
Language: Английский
Citations
7ACS Applied Bio Materials, Journal Year: 2024, Volume and Issue: 7(3), P. 2012 - 2022
Published: March 7, 2024
Triple-negative breast cancer (TNBC) remains a clinical challenge due to molecular, metabolic, and genetic heterogeneity as well the lack of validated drug targets. Thus, therapies or delivery paradigms are needed. Gold-derived compounds including FDA-approved drug, auranofin have shown promise effective anticancer agents against several tumors. To improve solubility bioavailability auranofin, we hypothesized that nanodelivery using biodegradable chitosan modified polyethylene glycol (PEG) nanoparticles (NPs) will enhance activity TNBC by comparing best nanoformulation with free drug. The selection was based on synthesis various PEG copolymers via formaldehyde-mediated engraftment onto form [chitosan-g-PEG] copolymer. Furthermore, altered physiochemical properties copolymer formaldehyde ratio towards (CP 1–4 NPs). Following recruitment polymer surface, explored how this process influenced stiffness nanoparticle atomic force microscopy (AFM), factor crucial for in vitro vivo studies. Our objective ensure full functionality inherent parent maintained without allowing overshadow chitosan's unique cationic while improving neutral pH. Hence, CP 2 NP chosen. demonstrate efficacy good carrier administered dose 3 mg/kg contrast which given at 5 mg/kg. In studies revealed potency encapsulated cells severe necrotic effect following treatment superior auranofin. conclusion, chitosan-g-PEG potential be an excellent system increasing its effectiveness potentially reducing limitations.
Language: Английский
Citations
6APOPTOSIS, Journal Year: 2024, Volume and Issue: 29(9-10), P. 1499 - 1514
Published: June 9, 2024
Language: Английский
Citations
5RSC Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Organometallic complexes offer a wide range of properties like structural variety, reaction kinetics, tunable lipophilicity and alternate mechanisms activation under physiological conditions compared to platinum chemotherapeutics are thus...
Language: Английский
Citations
0Biochemistry and Biophysics Reports, Journal Year: 2025, Volume and Issue: 42, P. 101996 - 101996
Published: April 1, 2025
Language: Английский
Citations
0Cancers, Journal Year: 2024, Volume and Issue: 16(13), P. 2319 - 2319
Published: June 25, 2024
Glioblastoma (GBM) is the most prevalent and advanced malignant primary brain tumor in adults. GBM frequently harbors epidermal growth factor receptor (EGFR) wild-type (EGFRwt) gene amplification and/or EGFRvIII activating mutation. EGFR-driven relies on thioredoxin (Trx) glutathione (GSH) antioxidant systems to withstand excessive production of reactive oxygen species (ROS). The impact EGFRwt or overexpression response a Trx/GSH co-targeting strategy unknown. In this study, we investigated context EGFR GBM. Auranofin reductase (TrxR) inhibitor, FDA-approved for rheumatoid arthritis. L-buthionine-sulfoximine (L-BSO) inhibits GSH synthesis by targeting glutamate–cysteine ligase catalytic (GCLC) enzyme subunit. We analyzed mechanisms cytotoxicity auranofin interaction between L-BSO U87MG, U87/EGFRwt, U87/EGFRvIII isogenic cell lines. ROS-dependent effects were assessed using N-acetylsteine. show that decreased TrxR1 activity increased ROS. vitality colony formation protein polyubiquitination through mechanisms, suggesting role ROS auranofin-induced three PARP-1 cleavage was associated with downregulation cells. Remarkably, combination induced significant depletion intracellular synergistic regardless overexpression. Nevertheless, molecular modulated different extent among exhibited prominent increase, P-AKT(Ser-473), AKT decrease along drastic downregulation. U87/EGFRwt displayed lower basal levels DNA damage compared U87MG Our study provides evidence vitro. Unraveling sensitivity EGFR-overexpressing cells alone, combination, supports rationale repurpose promising pro-oxidant treatment
Language: Английский
Citations
3Journal of Agricultural and Food Chemistry, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 11, 2024
Radiation-induced lung injury (RILI) is a prevalent complication of thoracic tumor radiotherapy and accidental radiation exposure. Pyrroloquinoline quinone (PQQ), novel vitamin B, plays crucial role in delaying aging, antioxidation, anti-inflammation, antiapoptosis. This study aims to investigate the protective effect mechanisms PQQ against RILI. C57BL/6 mice were exposed 20 Gy dose X-ray on entire thorax with or without daily oral administration for 2 weeks. effectively mitigated radiation-induced tissue damage, inflammation, oxidative stress, epithelial cell apoptosis. Additionally, significantly inhibited stress mitochondrial damage MLE-12 cells. Mechanistically, upregulated mRNA protein levels MOTS-c irradiated Knockdown by siRNA substantially attenuated effects In conclusion, alleviates RILI preserving function through MOTS-c-dependent mechanism, suggesting that may serve as promising nutraceutical intervention
Language: Английский
Citations
3Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 3, 2024
Language: Английский
Citations
1Published: Jan. 1, 2024
Auranofin (AF), an established gold (I) complex historically utilized in rheumatoid arthritis treatment, is being repurposed as a novel anticancer agent. This investigation assesses the chemosensitizing capacity of AF to potentiate cytotoxic effects doxorubicin (DOX) melanoma cell models, including drug-sensitive (B16F10) and multidrug-resistant (B16F10/ADR) variants. Our findings reveal that cotreatment with DOX markedly augments antitumor efficacy, evidenced by diminished viability augmented apoptotic rates. synergism attributed AF's ability inhibit thioredoxin reductase 1 (TrxR1), thereby compromising antioxidant defenses tumor cells elevating intracellular reactive oxygen species (ROS), which turn enhances pathways. Significantly, treatment mitigates heightened TrxR activity DOX-resistant cells, intensifying pro-oxidant culminating increased ROS production cellular demise.Employing molecular docking, dynamics (MD) simulations, surface plasmon resonance (SPR) assays, we systematically delineated interaction between TrxR1. data indicate exhibits high-affinity binding selenocysteine residue within catalytic site TrxR1, footprint partially overlaps endogenous substrate, (Trx), yet greater avidity. unique configuration instrumental impede reduction Trx thus instigating response cancer cells.In summation, this study underscores potential surmounting multidrug resistance therapy through redox modulation elucidates its mechanism action on These pave way for clinical application chemosensitizer, offering approach augment efficacy existing chemotherapy regimens.
Language: Английский
Citations
0Journal of Inorganic Biochemistry, Journal Year: 2024, Volume and Issue: 264, P. 112788 - 112788
Published: Nov. 29, 2024
Citations
0